We should treat more people with hepatitis B, experts say

We should treat more people with hepatitis B, experts say

In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B.

Hepatitis B drugs underused despite potential to save millions, says Lancet study

Hepatitis B causes over 3,000 deaths daily, with 20 to 40% of chronic cases at risk of dying without treatment, researchers have warned.

Hepatitis B drugs vastly underused, must be used early to save more lives: The Lancet

Hepatitis B drugs are being vastly underused, and boosting early treatment against the deadly hepatitis B virus (HBV) could save many lives over time, argued scientists in a new paper published in Lancet Gastroenterology and Hepatology.

We Should Treat More People with Hepatitis B, Experts Say

In a pair of articles published in Lancet Gastroenterology and Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B.